Blog - Products Liability

Posted on April 30, 2019 by Marty Aisenberg

Last week I wrote about the FDA’s decision to ban surgical mesh for transvaginal repair of pelvic organ prolapse (POP).  The FDA took this action only after tens of thousands of lawsuits were filed to recover for injuries caused by transvaginal mesh, 4 years of heightened FDA surveillance of transvaginal mesh complications, more than 2 years that the FDA gave the manufacturers to produce sufficient evidence that the benefits of transvaginal mesh repair of POP outweigh the risks, and an additional year for the FDA to determine that the manufacturers had not produced the required evidence. 

Posted on April 16, 2019 by Marty Aisenberg

The Second Circuit Court of Appeals recently resolved a split among its district courts on an issue relating to removal from state to federal court based on diversity jurisdiction.  Gibbons v.

Posted on April 2, 2019 by Arie George

I’m sure our readers will remember the multiple lawsuits filed against Ford in 2013, with attendant heavy media coverage, claiming that certain Ford vehicles were prone to unintended acceleration (UIA).  The cases were consolidated in the U.S.

Posted on February 21, 2019 by Peter George

Material for a law-related blog sometimes comes from an unexpected source.

Posted on January 10, 2019 by Marty Aisenberg

620 cases claiming that glyphosate (the active ingredient in Monsanto’s Roundup weed killer) causes cancer are pending in the U.S. District Court for the Northern District of California.

Posted on December 13, 2018 by Marty Aisenberg

The case is Smith v. Chrysler Group (5th Cir. 11/26/2018), http://www.ca5.uscourts.gov/opinions/pub/17/17-40901-CV0.pdf.   The opinion concisely summarizes the facts as follows:

Categories

ACA
FDA
Vident
2024 © Vident Partners.